Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphoma (vol 37, pg 1107, 2023)

被引：1
|
作者：
Muhsen, Ibrahim N.
Hill, LaQuisa C.
Ramos, Carlos A.
机构：
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 01期
关键词：
D O I：
10.1016/j.hoc.2023.11.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1121 / 1121
页数：1
相关论文
共 50 条
  • [21] The Use of Chimeric Antigen Receptor T Cells in Patients With Non-Hodgkin Lymphoma
    Lulla, Premal D.
    Hill, LaQuisa C.
    Ramos, Carlos A.
    Heslop, Helen E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (05) : 375 - 386
  • [22] Cardiovascular effects of chimeric antigen receptor t-cell therapy for refractory or relapsed non-hodgkin lymphoma
    Ganatra, S.
    Redd, R.
    Hayek, S.
    Parikh, R.
    Azam, T.
    Yanik, G.
    Spendley, L.
    Nikiforow, S.
    Jacobson, C.
    Nohria, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3263 - 3263
  • [23] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
    Cooper, Mathew L.
    DiPersio, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [24] A novel method to generate T-cell receptor deficient chimeric antigen receptor T cells
    Kamiya, Takahiro
    Wong, Desmond
    Png, Yi Tian
    Campana, Dario
    BLOOD ADVANCES, 2018, 2 (05) : 517 - 528
  • [25] Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients
    Harrer, Dennis Christoph
    Heidenreich, Martin
    Fante, Matthias Alexander
    Mueller, Viktoria
    Haehnel, Viola
    Offner, Robert
    Burkhardt, Ralph
    Herr, Wolfgang
    Edinger, Matthias
    Wolff, Daniel
    Thomas, Simone
    Brosig, Andreas
    TRANSFUSION, 2022, 62 (08) : 1602 - 1611
  • [26] A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
    Zhao, Houli
    Wang, Yiyun
    Yin, Elaine Tan Su
    Zhao, Kui
    Hu, Yongxian
    Huang, He
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 711 - 725
  • [27] A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
    Houli Zhao
    Yiyun Wang
    Elaine Tan Su Yin
    Kui Zhao
    Yongxian Hu
    He Huang
    Frontiers of Medicine, 2020, 14 : 711 - 725
  • [28] Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma
    Hamilton, Mark P.
    Miklos, David B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1053 - 1075
  • [29] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Zhou, Wenyujing
    Chen, Weihong
    Wan, Xiaochun
    Luo, Changru
    Du, Xin
    Li, Xiaoqing
    Chen, Qian
    Gao, Ruiwen
    Zhang, Xiaohan
    Xie, Mei
    Wang, Mingjun
    FRONTIERS IN GENETICS, 2022, 12
  • [30] Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
    Tbakhi, Bushra
    Reagan, Patrick M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
12345